SK283332B6 - Difenylalkyltetrahydropyridíny, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú - Google Patents

Difenylalkyltetrahydropyridíny, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú Download PDF

Info

Publication number
SK283332B6
SK283332B6 SK787-99A SK78799A SK283332B6 SK 283332 B6 SK283332 B6 SK 283332B6 SK 78799 A SK78799 A SK 78799A SK 283332 B6 SK283332 B6 SK 283332B6
Authority
SK
Slovakia
Prior art keywords
tetrahydropyridine
formula
group
ethyl
trifluoromethylphenyl
Prior art date
Application number
SK787-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK78799A3 (en
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK78799A3 publication Critical patent/SK78799A3/sk
Publication of SK283332B6 publication Critical patent/SK283332B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK787-99A 1996-12-13 1997-12-12 Difenylalkyltetrahydropyridíny, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú SK283332B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615336A FR2757161B1 (fr) 1996-12-13 1996-12-13 Diphenylalkyl-tetrahydropyridines
PCT/FR1997/002289 WO1998025904A1 (fr) 1996-12-13 1997-12-12 Diphenylalkyl-tetrahydropyridines, procede pour leur preparation et composition pharmaceutique les contenant

Publications (2)

Publication Number Publication Date
SK78799A3 SK78799A3 (en) 1999-12-10
SK283332B6 true SK283332B6 (sk) 2003-06-03

Family

ID=9498642

Family Applications (1)

Application Number Title Priority Date Filing Date
SK787-99A SK283332B6 (sk) 1996-12-13 1997-12-12 Difenylalkyltetrahydropyridíny, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú

Country Status (31)

Country Link
US (1) US6124318A (is)
EP (1) EP0950049B1 (is)
JP (1) JP2001505903A (is)
KR (1) KR100549656B1 (is)
CN (1) CN1144784C (is)
AT (1) ATE207056T1 (is)
AU (1) AU730142B2 (is)
BR (1) BR9713926A (is)
CA (1) CA2274946C (is)
CY (1) CY2282B1 (is)
CZ (1) CZ290242B6 (is)
DE (1) DE69707504T2 (is)
DK (1) DK0950049T3 (is)
EE (1) EE03764B1 (is)
ES (1) ES2167805T3 (is)
FR (1) FR2757161B1 (is)
HK (1) HK1024001A1 (is)
HU (1) HUP0001437A3 (is)
IL (2) IL130001A0 (is)
IS (1) IS2001B (is)
NO (1) NO313282B1 (is)
NZ (1) NZ336032A (is)
PL (1) PL192926B1 (is)
PT (1) PT950049E (is)
RS (1) RS49672B (is)
RU (1) RU2198874C2 (is)
SI (1) SI0950049T1 (is)
SK (1) SK283332B6 (is)
TR (1) TR199901290T2 (is)
UA (1) UA52708C2 (is)
WO (1) WO1998025904A1 (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
JP2003530432A (ja) * 2000-04-12 2003-10-14 ミナーヴァ・バイオテクノロジーズ・コーポレーション 神経変性疾患の治療
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
WO2005065661A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galanthamine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
BE775611A (fr) * 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US5266573A (en) * 1989-08-07 1993-11-30 Elf Sanofi Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser

Also Published As

Publication number Publication date
TR199901290T2 (xx) 1999-08-23
HUP0001437A3 (en) 2001-12-28
CY2282B1 (en) 2003-07-04
CN1240428A (zh) 2000-01-05
UA52708C2 (uk) 2003-01-15
IS5074A (is) 1999-06-10
DE69707504D1 (de) 2001-11-22
WO1998025904A1 (fr) 1998-06-18
IS2001B (is) 2005-04-15
RU2198874C2 (ru) 2003-02-20
NO992870L (no) 1999-08-11
YU26399A (sh) 2000-03-21
ATE207056T1 (de) 2001-11-15
AU5489598A (en) 1998-07-03
ES2167805T3 (es) 2002-05-16
NO313282B1 (no) 2002-09-09
FR2757161A1 (fr) 1998-06-19
DK0950049T3 (da) 2002-01-28
US6124318A (en) 2000-09-26
PL192926B1 (pl) 2006-12-29
NZ336032A (en) 2000-12-22
IL130001A (en) 2006-04-10
SI0950049T1 (en) 2002-10-31
EP0950049A1 (fr) 1999-10-20
RS49672B (sr) 2007-11-15
SK78799A3 (en) 1999-12-10
EP0950049B1 (fr) 2001-10-17
CA2274946C (en) 2005-09-20
CN1144784C (zh) 2004-04-07
NO992870D0 (no) 1999-06-11
AU730142B2 (en) 2001-03-01
JP2001505903A (ja) 2001-05-08
CA2274946A1 (en) 1998-06-18
CZ211099A3 (cs) 1999-09-15
HUP0001437A2 (hu) 2000-09-28
EE03764B1 (et) 2002-06-17
BR9713926A (pt) 2000-03-21
PL334073A1 (en) 2000-01-31
DE69707504T2 (de) 2002-06-27
CZ290242B6 (cs) 2002-06-12
HK1024001A1 (en) 2000-09-29
PT950049E (pt) 2002-03-28
IL130001A0 (en) 2000-02-29
KR20000069421A (ko) 2000-11-25
KR100549656B1 (ko) 2006-02-08
EE9900238A (et) 1999-12-15
FR2757161B1 (fr) 1999-03-12

Similar Documents

Publication Publication Date Title
JP3147906B2 (ja) 神経栄養活性および神経保護活性を有する4−アリール−1−フェニルアルキル−1,2,3,6−テトラヒドロピリジン
US4999355A (en) Isoindolinone derivatives, processes for preparing them and medicines containing them
SK283332B6 (sk) Difenylalkyltetrahydropyridíny, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
US7297799B2 (en) Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof
SK78699A3 (en) 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
MXPA99005651A (es) Uso de benzoilalquil-1,2,3,6-tetrahidropiridinas
MXPA99005108A (en) 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease